ZEMBRACE SYMTOUCH (nda208223)- (EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML))

Generic Name	SUMATRIPTAN SUCCINATE	Innovator	TONIX MEDS
Dosage	EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2036-Jan-29	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	ZEMBRACE SymTouch is a serotonin (5-HT1B/1D) receptoragonist(triptan) indicated for: *Acute treatment of migraine with or without aura in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	1

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ZEMBRACE SYMTOUCH